North Carolina’s life sciences news this week puts the capacity to do the work alongside the science itself. Progress depends ...
Topline three-month data from Cohort 2 expected in the first quarter of 2027, with potential pivotal Phase 3 trial dosing anticipated in the second half of 2027 ...
Collaboration pairs tissue and blood samples from disease-specific populations with patient outcomes data to power Network ...
First-of-its-kind platform and streamlined operating model strengthen Premier’s ability to help healthcare providers reduce ...
The BioTech Breakthrough Award recognizes Science 37’s Direct-to-Patient Site model for expanding patient access and delivering measurable clinical trial performance nationwide. MORRISVILLE, N.C., ...
Durham, 05 November 2026 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a ...
Expands life sciences portfolio through expertise in key precision pump technologies and solutions, adding approximately $40 ...
The gross proceeds to Precision from the offering, before deducting the underwriting discounts and commissions and offering ...
Waters Corporation, a Milford, Massachusetts-based life sciences and diagnostics company, has acquired MOBILion Systems, ...
Gaithersburg, Maryland’s Emergent BioSolutions received a delivery order modification valued at up to 3 million to supply ...
Collaboration provides no-cost exome testing for eligible patients with unexplained cholestasis, early-onset cataracts, or ...
The FDA review of NXT-41 (biologic surgical matrix without drug) remains on track, with a clearance decision anticipated this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results